(Reuters) -A consortium consisting of Warburg Pincus and KKR is in talks to acquire German packaging and medical equipment maker Gerresheimer AG, Bloomberg News reported on Wednesday, citing people familiar with the matter.
The private equity firms have emerged as the frontrunner after they teamed up and other potential bidders including Bain Capital dropped out, Bloomberg News said.
Gerresheimer, which makes pens used to inject weight loss drugs such as Novo Nordisk’s Wegovy, has a market capitalization of about 2.74 billion euros ($2.99 billion), according to LSEG data.
Warburg Pincus, KKR and Gerresheimer declined to comment on the report.
In February, the company confirmed it was in early-stage discussions with private equity investors over a potential sale of the company.
Gerresheimer also halved its revenue guidance for 2025 over weakness in its cosmetics and food and beverage segments and now expects organic revenue growth in the range of 3% to 5% in 2025, down from the previous range of 7% to 10%.
($1 = 0.9173 euros)
(Reporting by Pretish M J in Bengaluru; Editing by Krishna Chandra Eluri and Tasim Zahid)
